626 related articles for article (PubMed ID: 31048127)
1. Natural alkaloid harmine promotes degradation of alpha-synuclein via PKA-mediated ubiquitin-proteasome system activation.
Cai CZ; Zhou HF; Yuan NN; Wu MY; Lee SM; Ren JY; Su HX; Lu JJ; Chen XP; Li M; Tan JQ; Lu JH
Phytomedicine; 2019 Aug; 61():152842. PubMed ID: 31048127
[TBL] [Abstract][Full Text] [Related]
2. Lycorine, a natural alkaloid, promotes the degradation of alpha-synuclein via PKA-mediated UPS activation in transgenic Parkinson's disease models.
Zhu Q; Zhuang XX; Chen JY; Yuan NN; Chen Y; Cai CZ; Tan JQ; Su HX; Lu JH
Phytomedicine; 2021 Jul; 87():153578. PubMed ID: 34038839
[TBL] [Abstract][Full Text] [Related]
3. α-mangostin derivative 4e as a PDE4 inhibitor promote proteasomal degradation of alpha-synuclein in Parkinson's disease models through PKA activation.
Chen JY; Zhu Q; Cai CZ; Luo HB; Lu JH
Phytomedicine; 2022 Jul; 101():154125. PubMed ID: 35525236
[TBL] [Abstract][Full Text] [Related]
4. Tetramethylpyrazine Analogue T-006 Promotes the Clearance of Alpha-synuclein by Enhancing Proteasome Activity in Parkinson's Disease Models.
Zhou H; Shao M; Guo B; Li C; Lu Y; Yang X; ShengnanLi ; Li H; Zhu Q; Zhong H; Wang Y; Zhang Z; Lu J; Lee SM
Neurotherapeutics; 2019 Oct; 16(4):1225-1236. PubMed ID: 31313223
[TBL] [Abstract][Full Text] [Related]
5. Early-onset impairment of the ubiquitin-proteasome system in dopaminergic neurons caused by α-synuclein.
McKinnon C; De Snoo ML; Gondard E; Neudorfer C; Chau H; Ngana SG; O'Hara DM; Brotchie JM; Koprich JB; Lozano AM; Kalia LV; Kalia SK
Acta Neuropathol Commun; 2020 Feb; 8(1):17. PubMed ID: 32059750
[TBL] [Abstract][Full Text] [Related]
6. The role of ubiquitin linkages on alpha-synuclein induced-toxicity in a Drosophila model of Parkinson's disease.
Lee FK; Wong AK; Lee YW; Wan OW; Chan HY; Chung KK
J Neurochem; 2009 Jul; 110(1):208-19. PubMed ID: 19457126
[TBL] [Abstract][Full Text] [Related]
7. Oxyphylla A Promotes Degradation of α-Synuclein for Neuroprotection
Zhou H; Li S; Li C; Yang X; Li H; Zhong H; Lu JH; Lee SM
Aging Dis; 2020 May; 11(3):559-574. PubMed ID: 32489702
[TBL] [Abstract][Full Text] [Related]
8. Canthin-6-One Accelerates Alpha-Synuclein Degradation by Enhancing UPS Activity: Drug Target Identification by CRISPR-Cas9 Whole Genome-Wide Screening Technology.
Yuan NN; Cai CZ; Wu MY; Zhu Q; Su H; Li M; Ren J; Tan JQ; Lu JH
Front Pharmacol; 2019; 10():16. PubMed ID: 30745870
[TBL] [Abstract][Full Text] [Related]
9. Alpha-synuclein aggregation, Ubiquitin proteasome system impairment, and L-Dopa response in zinc-induced Parkinsonism: resemblance to sporadic Parkinson's disease.
Kumar V; Singh D; Singh BK; Singh S; Mittra N; Jha RR; Patel DK; Singh C
Mol Cell Biochem; 2018 Jul; 444(1-2):149-160. PubMed ID: 29198021
[TBL] [Abstract][Full Text] [Related]
10. Distinct alpha-Synuclein species induced by seeding are selectively cleared by the Lysosome or the Proteasome in neuronally differentiated SH-SY5Y cells.
Pantazopoulou M; Brembati V; Kanellidi A; Bousset L; Melki R; Stefanis L
J Neurochem; 2021 Mar; 156(6):880-896. PubMed ID: 32869336
[TBL] [Abstract][Full Text] [Related]
11. Reprint of: revisiting oxidative stress and mitochondrial dysfunction in the pathogenesis of Parkinson disease-resemblance to the effect of amphetamine drugs of abuse.
Perfeito R; Cunha-Oliveira T; Rego AC
Free Radic Biol Med; 2013 Sep; 62():186-201. PubMed ID: 23743292
[TBL] [Abstract][Full Text] [Related]
12. E46K Mutant α-Synuclein Is Degraded by Both Proteasome and Macroautophagy Pathway.
Yan JQ; Yuan YH; Chu SF; Li GH; Chen NH
Molecules; 2018 Nov; 23(11):. PubMed ID: 30388770
[TBL] [Abstract][Full Text] [Related]
13. Inhibition of Protein Ubiquitination by Paraquat and 1-Methyl-4-Phenylpyridinium Impairs Ubiquitin-Dependent Protein Degradation Pathways.
Navarro-Yepes J; Anandhan A; Bradley E; Bohovych I; Yarabe B; de Jong A; Ovaa H; Zhou Y; Khalimonchuk O; Quintanilla-Vega B; Franco R
Mol Neurobiol; 2016 Oct; 53(8):5229-51. PubMed ID: 26409479
[TBL] [Abstract][Full Text] [Related]
14. Alterations in lysosomal and proteasomal markers in Parkinson's disease: relationship to alpha-synuclein inclusions.
Chu Y; Dodiya H; Aebischer P; Olanow CW; Kordower JH
Neurobiol Dis; 2009 Sep; 35(3):385-98. PubMed ID: 19505575
[TBL] [Abstract][Full Text] [Related]
15. Distinct roles in vivo for the ubiquitin-proteasome system and the autophagy-lysosomal pathway in the degradation of α-synuclein.
Ebrahimi-Fakhari D; Cantuti-Castelvetri I; Fan Z; Rockenstein E; Masliah E; Hyman BT; McLean PJ; Unni VK
J Neurosci; 2011 Oct; 31(41):14508-20. PubMed ID: 21994367
[TBL] [Abstract][Full Text] [Related]
16. Effects of titanium dioxide nanoparticles on α-synuclein aggregation and the ubiquitin-proteasome system in dopaminergic neurons.
Wu J; Xie H
Artif Cells Nanomed Biotechnol; 2016; 44(2):690-4. PubMed ID: 25386730
[TBL] [Abstract][Full Text] [Related]
17. Silica nanoparticles induce alpha-synuclein induction and aggregation in PC12-cells.
Xie H; Wu J
Chem Biol Interact; 2016 Oct; 258():197-204. PubMed ID: 27613482
[TBL] [Abstract][Full Text] [Related]
18. Tetramethylpyrazine Nitrone Promotes the Clearance of Alpha-Synuclein via Nrf2-Mediated Ubiquitin-Proteasome System Activation.
Guo B; Zheng C; Cao J; Qiu X; Luo F; Li H; Lee SM; Yang X; Zhang G; Sun Y; Zhang Z; Wang Y
Neuromolecular Med; 2024 Apr; 26(1):9. PubMed ID: 38568291
[TBL] [Abstract][Full Text] [Related]
19. Antagonizing pathological α-synuclein-mediated neurodegeneration by J24335 via the activation of immunoproteasome.
Pan Z; Yu CW; Zhao C; Shao M; Yang X; Liang X; Li H; Lu Y; Ye Q; Chern JW; Lu J; Zhou H; Lee SM
Toxicol Appl Pharmacol; 2023 Dec; 480():116745. PubMed ID: 37931757
[TBL] [Abstract][Full Text] [Related]
20. Enhancing the Astrocytic Clearance of Extracellular α-Synuclein Aggregates by Ginkgolides Attenuates Neural Cell Injury.
Hua J; Yin N; Xu S; Chen Q; Tao T; Zhang J; Ding J; Fan Y; Hu G
Cell Mol Neurobiol; 2019 Oct; 39(7):1017-1028. PubMed ID: 31165943
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
